MXPA03001884A - Agregados de proteina vp22/acido nucleico y uso de los mismos. - Google Patents

Agregados de proteina vp22/acido nucleico y uso de los mismos.

Info

Publication number
MXPA03001884A
MXPA03001884A MXPA03001884A MXPA03001884A MXPA03001884A MX PA03001884 A MXPA03001884 A MX PA03001884A MX PA03001884 A MXPA03001884 A MX PA03001884A MX PA03001884 A MXPA03001884 A MX PA03001884A MX PA03001884 A MXPA03001884 A MX PA03001884A
Authority
MX
Mexico
Prior art keywords
protein
nucleic acid
acid aggregates
aggregates
cells
Prior art date
Application number
MXPA03001884A
Other languages
English (en)
Inventor
Peter Francis Joseph O'hare
Original Assignee
Phogen Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phogen Ltd filed Critical Phogen Ltd
Publication of MXPA03001884A publication Critical patent/MXPA03001884A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

Los agregados que comprenden proteina VP22 y oligonucleotidos o polinucleotidos pueden ser utilizados junto con un agente desagregante (de manera simultanea o secuencial) para tratar celulas objetivo mediante la liberacion de moleculas a las celulas y/o para prevenir la proliferacion celular y/o matar celulas.
MXPA03001884A 2000-09-08 2001-09-10 Agregados de proteina vp22/acido nucleico y uso de los mismos. MXPA03001884A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0022101.0A GB0022101D0 (en) 2000-09-08 2000-09-08 Delivery of substances to cells
PCT/GB2001/004057 WO2002020060A1 (en) 2000-09-08 2001-09-10 Vp22 protein/nucleic acid aggregates, uses thereof

Publications (1)

Publication Number Publication Date
MXPA03001884A true MXPA03001884A (es) 2004-04-20

Family

ID=9899119

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03001884A MXPA03001884A (es) 2000-09-08 2001-09-10 Agregados de proteina vp22/acido nucleico y uso de los mismos.

Country Status (8)

Country Link
US (2) US20020142960A1 (es)
EP (1) EP1315523A1 (es)
JP (1) JP2004508341A (es)
AU (1) AU2001286067A1 (es)
CA (1) CA2417660A1 (es)
GB (1) GB0022101D0 (es)
MX (1) MXPA03001884A (es)
WO (1) WO2002020060A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201234D0 (sv) * 2002-04-24 2002-04-24 Avaris Ab Transfer complex with added functionality and methods for its use
KR100591936B1 (ko) * 2002-11-12 2006-06-22 포휴먼텍(주) 세포내 ｄｎａ／ｒｎａ 전달 방법, 및 이것의 기초 및임상학적 응용
DE60332277D1 (de) * 2002-11-26 2010-06-02 Univ Massachusetts Verabreichung von sirnas
JP2006517790A (ja) * 2003-01-09 2006-08-03 インヴィトロジェン コーポレーション ポリペプチド−核酸複合体の細胞の送達および活性化

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE365808T1 (de) * 1995-07-28 2007-07-15 Marie Curie Cancer Care Transportproteine und deren verwendungen
DE19704979A1 (de) * 1996-02-07 1997-08-14 Max Delbrueck Centrum Retroviraler Vektor für den Gentransfer eines IL6-Antagonisten in humane hämatopoetische Stammzellen
US6017735A (en) * 1997-01-23 2000-01-25 Marie Curie Cancer Care Materials and methods for intracellular transport and their uses
DE60040274D1 (de) * 1999-03-10 2008-10-30 Phogen Ltd Verabreichung von nukleinsäuren und proteinen an zellen
GB9930519D0 (en) * 1999-12-24 2000-02-16 Phogen Limited Uses of transport proteins

Also Published As

Publication number Publication date
GB0022101D0 (en) 2000-10-25
AU2001286067A1 (en) 2002-03-22
CA2417660A1 (en) 2002-03-14
US20060189558A1 (en) 2006-08-24
EP1315523A1 (en) 2003-06-04
US20020142960A1 (en) 2002-10-03
WO2002020060A1 (en) 2002-03-14
JP2004508341A (ja) 2004-03-18

Similar Documents

Publication Publication Date Title
EP1159441B8 (en) Delivery of nucleic acids and proteins to cells
DE50006269D1 (de) Kombinationen zur einführung von nucleinsäuren in zellen
WO2003072711A3 (en) Method of using modified oligonucleotides for hepatic delivery
DE69637147D1 (de) Transportproteine und deren verwendungen
WO2003093469A3 (en) Methods for delivering nucleic acid molecules into cells and assessment thereof
AU2001265756A1 (en) Sleeping beauty, a transposon vector with a broad host range for the genetic transfprmation in vertebrates
HK1082761A1 (en) Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
EP1541690A3 (en) Transfer of mRNA using polycationic compounds
BRPI0409911A (pt) método para liberar uma molécula em uma célula, e, complexo carreador
MX2007003167A (es) Asministracion de polinucleotidos.
MXPA02001726A (es) Celda de combustible y placa bipolar para utilizarse con la misma.
MX2007008980A (es) Acidos nucleicos para apoptosis de celulas cancerigenas.
MY138257A (en) Compositions and methods for enhancing delivery of therapeutic agents to cells
ES2172180T3 (es) Polimeros cationicos, complejos que asocian dichos polimeros cationicos y sustancias terapeuticamente activas que comprenden por lo menos una carga negativa, en particular unos acidos nucleicos, y su utilizacion en terapia genica.
MXPA03006984A (es) Secuencia de nucleotidos que median la fertilidad masculina y metodo de uso de la misma.
ID27760A (id) Poliketida-poliketida, pembuatannya, dan bahan-bahan untuk penggunaannya
MXPA03001884A (es) Agregados de proteina vp22/acido nucleico y uso de los mismos.
WO2006014234A3 (en) Novel recombinant poxvirus composition and uses thereof
TW200502390A (en) Sequence specific DNA recombination in eukaryotic cells
WO2003092736A3 (en) Peptide nucleic acid conjugates with transporter peptides
WO2004079332A3 (en) Composition and method for increasing efficiency of introduction of target substance into cell
WO2004108898A3 (en) Transfection agents
AU4395599A (en) (-)-strand rna virus vector for nerve cell
WO2004110356A3 (en) Methods for modulating cell-to-cell adhesion using an agonist of c1inh-type protein activity
PT1537210E (pt) Inibicao de oliconucleotidos decoy de expressao cd-40